Discrepancies in estradiol levels in a premenopausal woman receiving abemaciclib despite ovarian function suppression and bilateral salpingo-oophorectomy

Abemaciclib is approved for use in the adjuvant setting in combination with endocrine therapy for patients with high-risk, hormone receptor-positive, HER2-negative early-stage breast cancer based on the monarchE trial. Options for endocrine therapy for premenopausal women include an aromatase inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kessler, Alaina J., Patel, Rima, Gallagher, Emily Jane, Shao, Theresa, Fasano, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137258/
https://www.ncbi.nlm.nih.gov/pubmed/37124155
http://dx.doi.org/10.1016/j.cpccr.2023.100224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137258/
https://www.ncbi.nlm.nih.gov/pubmed/37124155
http://dx.doi.org/10.1016/j.cpccr.2023.100224

Ejemplares similares